Corbus Pharmaceuticals Holdings, Inc. Future Minimum Sublease Rentals, Sale Leaseback Transactions, Due in Rolling Year Two
Corbus Pharmaceuticals Holdings, Inc. (CRBP) had Future Minimum Sublease Rentals, Sale Leaseback Transactions, Due in Rolling Year Two of $104.97 thousand as of 2021-09-30, per its 10-Q filed 2021-11-12.
Discontinued › Notes › Leases
us-gaap:FutureMinimumSubleaseRentalsSaleLeasebackTransactionsDueInRollingYearTwo · last filed 2021-11-12
- 2021-09-30: Future Minimum Sublease Rentals, Sale Leaseback Transactions, Due in Rolling Year Two $104.97K.
| Period end | Future Minimum Sublease Rentals, Sale Leaseback Transactions, Due in Rolling Year Two |
|---|---|
| 2021-09-30 | $104.97K 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |